acebutolol has been researched along with Shock in 2 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eibs, HG | 1 |
| Oberdisse, U | 1 |
| Brambach, U | 1 |
| Tirlapur, VG | 1 |
| Evans, PJ | 1 |
| Jones, MK | 1 |
2 other studies available for acebutolol and Shock
| Article | Year |
|---|---|
[Intoxication by beta-blockers in children and adolescents (author's transl)].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Child, Preschool; Female; Glucagon; Humans; Hyp | 1982 |
Shock syndrome after acebutolol.
Topics: Acebutolol; Angina Pectoris; Humans; Male; Middle Aged; Shock | 1986 |